Loading clinical trials...
Loading clinical trials...
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3814916 in healthy male and female trial participants.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Boehringer Ingelheim
NCT06631261 · Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched
NCT00090662 · Healthy Volunteer
NCT07137312 · Solid Tumor, Healthy, and more
NCT06657768 · Alzheimer Disease, Healthy
NCT07612852 · Life Style, Healthy, Risk Reduction, and more
SGS Life Science Services - Clinical Research
Edegem
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions